PGY-3 @HMHNeurology 🇺🇸 | Former Vice President @IFMSA_Pakistan 🇵🇰 | Former Research Volunteer @TuftsMedicalCtr | Aspiring Vascular Neurologist | KEMU’21
We had a wonderful time at the TNS Happy Hour during #AANAM. It was great to see our Texas friends in Chicago! Many thanks to @Supernus_Pharma for sponsoring the event. 🧠
sICH risk post IVT in CAA seems to be driven by microbleeds and superficial siderosis. Check out this terrific study by my colleagues from Canada 🇨🇦 showing the risk of symptomatic intracranial hemorrhage was only seen in Boston 1.0 and 1.5 and not 2.0. https://t.co/FdI22ynbKg
The new AHA acute stroke guidelines are out. These reflect comprehensive available evidence in acute ischemic stroke including systems of care, use of TNK, EVT eligibility, antithrombotic use, pediatric stroke, and management of cytotoxic brain edema. https://t.co/iGSiy3mMHk
Deadline is tomorrow! ❗️Residents—don’t miss your opportunity to participate in the TNS Resident Poster Competition. Share your work, gain visibility among Texas neurologists, and be part of the scientific exchange at our Annual Conference. https://t.co/VcPGmk6N8V #TNSW2026
We’re “having a ball” getting ready for FIFA World Cup 2026™! As a way to celebrate, we commissioned artist Betirri to hand paint soccer ball art pieces to be displayed at each of our hospitals. We are proud to be an Official Houston World Cup 2026 Host City Supporter™
Just landed in the session “Updates in Vascular Neurology” moderated by @NuroseKarim at #SVIN2025 — the field is evolving faster than ever. Excited to hear the newest on large core, STOP CAD and arterial dissections. 🚀🧠 l
A prolific day for the fields of #Vascular & #Interventional#Neurology here at @svinsociety#SVIN25#CREST2 Results 🚨
CAS + IMM > IMM alone, lower risk of periop stroke/death within 4y for asymptomatic high grade carotid stenosis, no sig benefit in CEA arm
Watch. To. The. End.
#SVIN2025 just casually dropped a bombshell:
CREST-2 says carotid stenting > CEA + medical management.
Yes, you read that right.
The data has spoken: ARD 3.2%, RR 2.13, and the p-value didn’t come to play.
The plenary hall was purely electric.
You could feel the field shift in real time.
Carotid artery stenting for the win for asymptomatic severe carotid stenosis. Very impressive trial by the CREST-2 team. Congratulations! @ChaturvediNeuro#SVIN25 https://t.co/cYJQxW4DYL
A message from your #TNSW2026 Program Director! 📣 This year's lineup includes hands-on skills workshops for trainees, a 5K fun run/walk, exciting educational sessions, and a can't-miss evening with Dr. Glaucomflecken! https://t.co/nOhRrtTHx2
A message from your #TNSW2026 Program Director! 📣 This year's lineup includes hands-on skills workshops for trainees, a 5K fun run/walk, exciting educational sessions, and a can't-miss evening with Dr. Glaucomflecken! https://t.co/nOhRrtTHx2
Exciting news! 🎉 @DGlaucomflecken will be joining us LIVE at #TNSW2026 in Austin! Online registration is open + you can take advantage of early bird pricing when you sign up before January 9th. See y’all there! 🧠 https://t.co/kfMji3Zgbp